UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Disposition of Docosahexaenoic acid-paclitaxel, a novel taxane, in blood: In vitro and clinical pharmacokinetic studies

Clinical cancer research, 2003, Vol.9 (1), p.151-159

2003

Volltextzugriff (PDF)

Troxacitabine, A Novel Dioxolane Nucleoside Analog, Has Activity in Patients With Advanced Leukemia

Journal of clinical oncology, 2001-02, Vol.19 (3), p.762-771

2001

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of the Mitochondrial-specific Rhodacyanine Dye Analog MKT 077

Clinical cancer research, 2000-01, Vol.6 (1), p.42-49

2000

Volltextzugriff (PDF)

Population Pharmacokinetic Model for Topotecan Derived From Phase I Clinical Trials

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2459-2467

2000

Volltextzugriff (PDF)

Population Pharmacokinetics of Troxacitabine, a Novel Dioxolane Nucleoside Analogue

Clinical cancer research, 2006-04, Vol.12 (7), p.2158-2165

2006

Volltextzugriff (PDF)

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3085-3096

1996

Volltextzugriff (PDF)

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3074-3084

1996

Volltextzugriff (PDF)

Phase I and Pharmacologic Study of Oral Fluorouracil on a Chronic Daily Schedule in Combination With the Dihydropyrimidine Dehydrogenase Inactivator Eniluracil

Journal of clinical oncology, 2000-02, Vol.18 (4), p.915-926

2000

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Irofulven, a Novel Mushroom-Derived Cytotoxin, Administered for Five Consecutive Days Every Four Weeks in Patients With Advanced Solid Malignancies

Journal of clinical oncology, 2000-12, Vol.18 (24), p.4086-4097

2000

Volltextzugriff (PDF)

Paclitaxel Steady-State Plasma Concentration as a Determinant of Disease Outcome and Toxicity in Lung Cancer Patients Treated with Paclitaxel and Cisplatin

Clinical cancer research, 1999-04, Vol.5 (4), p.767-774

1999

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Temozolomide and Cisplatin in Patients with Advanced Solid Malignancies

Clinical cancer research, 1999-07, Vol.5 (7), p.1629-1637

1999

Volltextzugriff (PDF)

Temozolomide in Patients with Advanced Cancer: Phase I and Pharmacokinetic Study

Pharmacotherapy, 2004-01, Vol.24 (1), p.16-25

2004

Volltextzugriff (PDF)

Oral Paclitaxel and Concurrent Cyclosporin A: Targeting Clinically Relevant Systemic Exposure to Paclitaxel

Clinical cancer research, 2000-09, Vol.6 (9), p.3459-3468

2000

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Novel l-Nucleoside Analog Troxacitabine Given as a 30-Minute Infusion Every 21 Days

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2567-2574

2002

Volltextzugriff (PDF)

Phase I and Pharmacologic Study of the Tyrosine Kinase Inhibitor SU101 in Patients With Advanced Solid Tumors

Journal of clinical oncology, 1999-04, Vol.17 (4), p.1095-1104

1999

Volltextzugriff (PDF)

Distribution of paclitaxel in plasma and cerebrospinal fluid

Anti-cancer drugs, 2003-06, Vol.14 (5), p.365-368

2003

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks

Clinical cancer research, 1998-03, Vol.4 (3), p.595-604

1998

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2770-2779

1998

Volltextzugriff (PDF)

A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia

Clinical cancer research, 1996-12, Vol.2 (12), p.1921-1930

1996

Volltextzugriff (PDF)

Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study

Journal of clinical oncology, 1997-01, Vol.15 (1), p.177-186

1997

Volltextzugriff (PDF)

A phase I and pharmacologic study of DMP 840 administered by 24-hour infusion

Annals of oncology, 1998-01, Vol.9 (1), p.101-104

1998

Volltextzugriff (PDF)

High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: A phase II and pharmacodynamic study

Annals of oncology, 1998-02, Vol.9 (2), p.173-180

1998

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Losoxantrone and Paclitaxel in Patients with Advanced Solid Tumors

Clinical cancer research, 1999-02, Vol.5 (2), p.299-308

1999

Volltextzugriff (PDF)

Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma : A Gynecologic Oncology Group Study

American journal of clinical oncology, 2000-12, Vol.23 (6), p.609-613

2000

Volltextzugriff (PDF)

Multistate Outbreak of Listeriosis Linked to Turkey Deli Meat and Subsequent Changes in US Regulatory Policy

Clinical infectious diseases, 2006-01, Vol.42 (1), p.29-36

2006

Volltextzugriff (PDF)

26 – 50 von 73

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(73)

Sprache

Englisch
(73)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disposition of Docosahexaenoic acid-paclitaxel, a novel taxane, in blood: In vitro and clinical pharmacokinetic studies

Troxacitabine, A Novel Dioxolane Nucleoside Analog, Has Activity in Patients With Advanced Leukemia

A Phase I and Pharmacokinetic Study of the Mitochondrial-specific Rhodacyanine Dye Analog MKT 077

Population Pharmacokinetic Model for Topotecan Derived From Phase I Clinical Trials

Population Pharmacokinetics of Troxacitabine, a Novel Dioxolane Nucleoside Analogue

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

Phase I and Pharmacologic Study of Oral Fluorouracil on a Chronic Daily Schedule in Combination With the Dihydropyrimidine Dehydrogenase Inactivator Eniluracil

Phase I and Pharmacokinetic Study of Irofulven, a Novel Mushroom-Derived Cytotoxin, Administered for Five Consecutive Days Every Four Weeks in Patients With Advanced Solid Malignancies

Paclitaxel Steady-State Plasma Concentration as a Determinant of Disease Outcome and Toxicity in Lung Cancer Patients Treated with Paclitaxel and Cisplatin

A Phase I and Pharmacokinetic Study of Temozolomide and Cisplatin in Patients with Advanced Solid Malignancies

Temozolomide in Patients with Advanced Cancer: Phase I and Pharmacokinetic Study

Oral Paclitaxel and Concurrent Cyclosporin A: Targeting Clinically Relevant Systemic Exposure to Paclitaxel

Phase I and Pharmacokinetic Study of Novel l-Nucleoside Analog Troxacitabine Given as a 30-Minute Infusion Every 21 Days

Phase I and Pharmacologic Study of the Tyrosine Kinase Inhibitor SU101 in Patients With Advanced Solid Tumors

Distribution of paclitaxel in plasma and cerebrospinal fluid

Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks

Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies

A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia

Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study

A phase I and pharmacologic study of DMP 840 administered by 24-hour infusion

High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: A phase II and pharmacodynamic study

A Phase I and Pharmacokinetic Study of Losoxantrone and Paclitaxel in Patients with Advanced Solid Tumors

Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma : A Gynecologic Oncology Group Study

Multistate Outbreak of Listeriosis Linked to Turkey Deli Meat and Subsequent Changes in US Regulatory Policy

Aktive Filter

Suchergebnisse filtern